Evaluation of CD39, CD73, HIF-1α, and their related miRNAs expression in decidua of preeclampsia cases compared to healthy pregnant women

Yousef Yousefzadeh(Tabriz University of Medical Sciences), Mehdi Yousefi(Tabriz University of Medical Sciences), Shahla Danaii(Academic Center for Education, Culture and Research), Forough Parhizkar(Tabriz University of Medical Sciences), Leili Aghebati‐Maleki(Tabriz University of Medical Sciences), Sima Shahmohammadi Farid(Tabriz University of Medical Sciences), Simin Taghavi(Tabriz University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Javad Ahmadian Heris(Tabriz University of Medical Sciences), Hossein Samadi Kafil(Tabriz University of Medical Sciences), Ladan Kalafi(Tabriz University of Medical Sciences), Ata Mahmoodpoor(Tabriz University of Medical Sciences), Mohammad Sadegh Soltani‐Zangbar(Tabriz University of Medical Sciences), Farhad Jadidi-Niaragh(Tabriz University of Medical Sciences), Ali Tarbiat(Urmia University)
Molecular Biology Reports
September 1, 2022
10.1007/s11033-022-07887-z
Cited by 15

Related Papers

Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019
|BMJ|2022|849
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202
CDK1 in Breast Cancer: Implications for Theranostic Potential
|Anti-Cancer Agents in Medicinal Chemistry|2020|169